Search Results - "Griffiths, Gary L."

Refine Results
  1. 1

    Near-Infrared Photoimmunotherapy: Photoactivatable Antibody–Drug Conjugates (ADCs) by Kobayashi, Hisataka, Griffiths, Gary L, Choyke, Peter L

    Published in Bioconjugate chemistry (15-01-2020)
    “…Cancer treatment has been founded traditionally on the three approaches of surgery, radiation, and chemotherapy with the latter recognized as the obvious…”
    Get full text
    Journal Article
  2. 2

    Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol[S] by Zhu, Xuewei, Owen, John S., Wilson, Martha D., Li, Haitao, Griffiths, Gary L., Thomas, Michael J., Hiltbold, Elizabeth M., Fessler, Michael B., Parks, John S.

    Published in Journal of lipid research (01-11-2010)
    “…We previously showed that macrophages from macrophage-specific ATP-binding cassette transporter A1 (ABCA1) knockout (Abca1-M/-M) mice had an enhanced…”
    Get full text
    Journal Article
  3. 3

    Salivary excretion of systemically injected [ 18 F]DCFPyL in prostate cancer patients undergoing PSMA scans by Fernandes, Bruna, Roy, Jyoti, Basuli, Falguni, Warner, Blake M, Lindenberg, Liza, Mena, Esther, Adler, Steven S, Griffiths, Gary L, Choyke, Peter L, Lin, Frank I

    Published in Frontiers in oncology (23-04-2024)
    “…Prostate-specific membrane antigen (PSMA) is present in high amounts in salivary glands, but it is unclear whether labeled binders of PSMA are excreted in the…”
    Get full text
    Journal Article
  4. 4

    Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors by Sarin, Hemant, Kanevsky, Ariel S, Wu, Haitao, Sousa, Alioscka A, Wilson, Colin M, Aronova, Maria A, Griffiths, Gary L, Leapman, Richard D, Vo, Howard Q

    Published in Journal of translational medicine (23-06-2009)
    “…The existence of large pores in the blood-tumor barrier (BTB) of malignant solid tumor microvasculature makes the blood-tumor barrier more permeable to…”
    Get full text
    Journal Article
  5. 5

    Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells by Sarin, Hemant, Kanevsky, Ariel S, Wu, Haitao, Brimacombe, Kyle R, Fung, Steve H, Sousa, Alioscka A, Auh, Sungyoung, Wilson, Colin M, Sharma, Kamal, Aronova, Maria A, Leapman, Richard D, Griffiths, Gary L, Hall, Matthew D

    Published in Journal of translational medicine (18-12-2008)
    “…Effective transvascular delivery of nanoparticle-based chemotherapeutics across the blood-brain tumor barrier of malignant gliomas remains a challenge. This is…”
    Get full text
    Journal Article
  6. 6

    Near-Infrared Fluorescence Lifetime pH-Sensitive Probes by Berezin, Mikhail Y., Guo, Kevin, Akers, Walter, Northdurft, Ralph E., Culver, Joseph P., Teng, Bao, Vasalatiy, Olga, Barbacow, Kyle, Gandjbakhche, Amir, Griffiths, Gary L., Achilefu, Samuel

    Published in Biophysical journal (20-04-2011)
    “…We report what we believe to be the first near-infrared pH-sensitive fluorescence lifetime molecular probe suitable for biological applications in…”
    Get full text
    Journal Article
  7. 7

    Preparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging by Opina, Ana Christina, Wong, Karen J, Griffiths, Gary L, Turkbey, Baris I, Bernardo, Marcelino, Nakajima, Takahito, Kobayashi, Hisataka, Choyke, Peter L, Vasalatiy, Olga

    Published in Nanomedicine (London, England) (01-05-2015)
    “…To demonstrate the use of gadolinium (Gd)-labeled dendrimers as lymphatic imaging agents and establish the long-term biodistribution (90-day) of this type of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent by Hyodo, Fuminori, Chuang, Kai-Hsiang, Goloshevsky, Artem G, Sulima, Agnieszka, Griffiths, Gary L, Mitchell, James B, Koretsky, Alan P, Krishna, Murali C

    “…Reactive oxygen species (ROS) and compromised antioxidant defense may contribute to brain disorders such as stroke, amyotrophic lateral sclerosis, etc…”
    Get full text
    Journal Article
  10. 10

    Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys by Sapra, Puja, Stein, Rhona, Pickett, Jennifer, Qu, Zhengxing, Govindan, Serengulam V, Cardillo, Thomas M, Hansen, Hans J, Horak, Ivan D, Griffiths, Gary L, Goldenberg, David M

    Published in Clinical cancer research (15-07-2005)
    “…Purpose: IMMU-110 is a drug immunoconjugate composed of doxorubicin conjugated to the humanized anti-CD74 monoclonal antibody, hLL1, at a…”
    Get full text
    Journal Article
  11. 11

    Development of a MR-Visible Compound for Tracing Neuroanatomical Connections In Vivo by Wu, Carolyn W.-H., Vasalatiy, Olga, Liu, Ning, Wu, Haitao, Cheal, Sarah, Chen, Der-Yow, Koretsky, Alan P., Griffiths, Gary L., Tootell, Roger B.H., Ungerleider, Leslie G.

    Published in Neuron (Cambridge, Mass.) (28-04-2011)
    “…Traditional studies of neuroanatomical connections require injection of tracer compounds into living brains, then histology of the postmortem tissue. Here, we…”
    Get full text
    Journal Article
  12. 12

    (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies by Sato, Noriko, Wu, Haitao, Asiedu, Kingsley O, Szajek, Lawrence P, Griffiths, Gary L, Choyke, Peter L

    Published in Radiology (01-05-2015)
    “…To develop a clinically translatable method of cell labeling with zirconium 89 ((89)Zr) and oxine to track cells with positron emission tomography (PET) in…”
    Get full text
    Journal Article
  13. 13

    Translating a radiolabeled imaging agent to the clinic by Griffiths, Gary L., Vasquez, Crystal, Escorcia, Freddy, Clanton, Jeff, Lindenberg, Liza, Mena, Esther, Choyke, Peter L.

    Published in Advanced drug delivery reviews (01-02-2022)
    “…[Display omitted] Molecular Imaging is entering the most fruitful, exciting period in its history with many new agents under development, and several reaching…”
    Get full text
    Journal Article
  14. 14

    Preclinical Imaging of Prostate Cancer by Olkowski, Colleen, Fernandes, Bruna, Griffiths, Gary L., Lin, Frank, Choyke, Peter L.

    Published in Seminars in nuclear medicine (01-09-2023)
    “…Prostate cancer remains a major cause of mortality and morbidity, affecting millions of men, with a large percentage expected to develop the disease as they…”
    Get full text
    Journal Article
  15. 15

    Cure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate by GRIFFITHS, Gary L, MATTES, M. Jules, STEIN, Rhona, GOVINDAN, Serengulam V, HORAK, Ivan D, HANSEN, Hans J, GOLDENBERG, David M

    Published in Clinical cancer research (15-12-2003)
    “…Purpose: The purpose of this research was to test the therapeutic efficacy of an anthracycline-antibody conjugate for the treatment of human B-cell lymphoma in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy by Sharkey, Robert M, Karacay, Habibe, Richel, Heidi, McBride, William J, Rossi, Edmund A, Chang, Ken, Yeldell, Dion, Griffiths, Gary L, Hansen, Hans J, Goldenberg, David M

    Published in Clinical cancer research (01-09-2003)
    “…Purpose: With increasing interest in pretargeting procedures for improving the delivery of radionuclides for cancer imaging and therapy, this investigation was…”
    Get full text
    Journal Article
  19. 19
  20. 20